CSIMarket Company Name, Ticker, Industry, else..


Amgen Inc   (AMGN)
Other Ticker:  
 

Amgen Inc

AMGN's Fundamental analysis



Amgen Inc 's sales fell by -2.13 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 382

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -13.45 %

Amgen Inc 's net income grew by 92.48 % in I. Quarter 2023 year on year, above company average,

• More on AMGN's Growth


Amgen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Amgen Inc PEG ratio is at 0.33 Company is currently trading with Price to Cash flow multiple of 4.66 in trailing twelve-month period.
Company
14.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.46.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.54.


• More on AMGN's Valuation
 
 Total Debt (Millions $) 61,595
 Dividend TTM ($) 7.9 $
 Dividend Yield TTM (%) 3.9 %
 Revenue/Employee (TTM) $ 1,082,231
 Net Income/Employee (TTM) $ 327,149
 Receivable Turnover (TTM) 4.77
 Tangible Book Value (Per Share $) -47.54

Amgen Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Amgen Inc PEG ratio is at 0.33 Company is currently trading with Price to Cash flow multiple of 4.66 in trailing twelve-month period.
Company
14.72
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.46.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.54.

Amgen Inc Price to Book Ratio is at 21.82 higher than Indusry Avg. of 4.19, and lower than S&P 500 Avg. of 1255.17

• More on AMGN's Valuation

•  Market Capitalization (Millions $) 116,708
•  Shares Outstanding (Millions) 538
•  Employees 24,200
•  Revenues (TTM) (Millions $) 26,190
•  Net Income (TTM) (Millions $) 7,917
•  Cash Flow (TTM) (Millions $) 25,032
•  Capital Exp. (TTM) (Millions $) -1,090
•  Total Debt (Millions $) 61,595
•  Dividend TTM ($) 7.9 $
•  Dividend Yield TTM (%) 3.9 %
•  Revenue/Employee (TTM) $ 1,082,231
•  Net Income/Employee(TTM) $ 327,149
•  Receivable Turnover Ratio (TTM) 4.77
•  Tangible Book Value (Per Share $) -47.54

•  Market Capitalization (Millions $) 116,708
•  Shares Outstanding (Millions) 538
•  Employees 24,200
•  Revenues (TTM) (Millions $) 26,190
•  Net Income (TTM) (Millions $) 7,917
•  Cash Flow (TTM) (Millions $) 25,032
•  Capital Exp. (TTM) (Millions $) -1,090


    AMGN's Profitability Comparisons
Amgen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 31.47 % from 32.61 % in IV. Quarter.

Amgen Inc net profit margin of 46.54 % is currently ranking no. 7 in Biotechnology & Pharmaceuticals industry, ranking no. 20 in Healthcare sector and number 190 in S&P 500.


Profitability by Segment



  Ratio
•   Capital Ratio (MRQ) 3.14
•  Total Debt to Equity (MRQ) 11.52
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.38
•  Inventory Turnover Ratio (TTM) 1.36



Amgen Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 31.47 % from 32.61 % in IV. Quarter.

Amgen Inc net profit margin of 46.54 % is currently ranking no. 7 in Biotechnology & Pharmaceuticals industry, ranking no. 20 in Healthcare sector and number 190 in S&P 500.

• More on AMGN's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071